Published in Pharma Law Weekly, March 27th, 2007
Pursuant to the final settlement of this matter, the participation rate was lower than previously estimated. As a result, the Company will favorably adjust its prior accrual for this legal settlement charge by approximately $2.1 million pre-tax, which equates to approximately $1.3 million after-tax or $0.04 per diluted share. Due to the timing of this final settlement, the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly